genetic engineering

Bacteria have been linked to cancer treatment for more than a century. Now researchers are trying to turn them into actual therapies.

Analysis of two pivotal Yescarta clinical trials revealed that patients' germline DNA influences both toxicity risk and CAR T expansion, opening new opportunities for smarter cell therapy design.

Since their discovery in the 1890s, viruses have intrigued scientists as potential cancer-killing agents.

For cases where gene editing simply won’t work, biochemist Aseem Ansari is working on a new idea: changing how cells regulate genes.

Genetically engineered bacteria could help diagnose or monitor gut diseases.